Drug Treatments for Heart Disease

Effective drug treatments for heart disease can help lower blood pressure or cholesterol, prevent or dissolve blood clots, relieve and prevent angina symptoms or improve the strength or rhythm of the heart's contractions.

Follow the links below to find information on drug treatments for heart disease.

Reviewed March 2009

Printer friendly page

Related HealthInsite Topics

Systematic Reviews of Drug Treatments for Heart Disease
HealthInsite Topic Page
Links to systematic reviews of the evidence for the effectiveness of drug treatments for heart disease.

32 Resources Found
Results 1 to 20 displayed.
1    2   

Title:   Anticipated shortage of injectable Indomethacin (Indocid PDA)
Publisher:   Australian Government Department of Health and Ageing
Description:   Advice from the Therapeutic Goods Administration about the anticipated shortage of injectable Indomethacin (Indocid PDA)
Date:   Jan 2010

Title:   Heart failure overview - myDr.com.au
Publisher:   myDr
Description:   Heart failure means the heart has a reduced ability to pump blood around the body.
Date:   Jun 2009

Title:   Congestive heart failure
Publisher:   Better Health Channel
Description:   Congestive heart failure occurs when the heart cannot pump enough blood to satisfy the needs of the body. The most common cause of congestive heart failure is coronary heart disease. Symptoms include breathlessness during activity and at rest, muscular fatigue, swelling of ankles, legs or the abdomen and unexplained coughing and wheezing.
Date:   Nov 2008

Title:   Lowering cholesterol
Publisher:   Australian Prescriber
Description:   Lowering the person's cholesterol will lower their risk of heart disease.
Date:   Oct 2008

Title:   How to treat hypercholesterolaemia
Publisher:   Australian Prescriber
Description:   Elevated LDL cholesterol is a major risk factor for coronary heart disease and is the major target of therapy to prevent coronary events.
Date:   Oct 2008

Title:   Angina treatments - myDr.com.au
Publisher:   myDr
Description:   Most angina medicines and treatments for angina either make the heart pump more slowly or improve blood flow to the heart.
Date:   Jun 2008

Title:   Link between heart disease & reproductive hormone relaxin
Publisher:   Virtual Medical Centre.com
Description:   What is Relaxin? Relaxin- a marker of heart disease? Functional role for relaxin? Therapeutic potential of relaxin? Future research on relaxin
Date:   May 2008

Title:   Heart disease and HT
Publisher:   The Jean Hailes Foundation for Women's Health
Description:   The Jean Hailes Foundation answers your questions about the findings of the Women's Health Initiative Estrogen plus Progestin Study, published in the New England Journal of Medicine August 7, 2003.
Date:   May 2008

Title:   Treating blocked arteries (Comments for consumers)
Publisher:   Australian Prescriber
Description:   When a coronary artery gets blocked it can cause a heart attack. After a blockage is removed a device called a stent may be used to keep the artery open.
Date:   Aug 2007

Title:   Antiplatelet therapy after coronary occlusion
Publisher:   Australian Prescriber
Description:   Platelets are pivotal in the pathogenesis of acute coronary syndrome and in the complications following the implantation of coronary stents.
Date:   Aug 2007

Title:   Triglycerides - myDr.com.au
Publisher:   myDr
Description:   Find out about triglycerides, a type of fat found in your blood.
Date:   Mar 2007

Title:   Amiodarone
Publisher:   Australian Prescriber
Description:   Amiodarone is the most effective antiarrhythmic drug available. It is a difficult and challenging drug to use in clinical practice. This is because of its very prolonged half-life and because of its multiple adverse effects.
Date:   Dec 2005

Title:   Use of evidence-based management for acute coronary syndrome
Publisher:   New Zealand Guidelines Group (NZGG)
Description:   This study compared the management of acute coronary syndrome (ACS) for patients admitted to Dunedin Coronary Care with evidence-based recommendations from the American College of Cardiology / American Heart Association in 1999 and 2002 and with management reported in international and local registries.
Date:   Oct 2005

Title:   Non ST-elevation acute coronary syndromes: New Zealand Management Guidelines
Publisher:   New Zealand Guidelines Group (NZGG)
Description:   These guidelines apply to the management of patients with non-ST elevation acute coronary syndromes (NSTEACS). The purpose of these guidelines is to provide a summary of the most up to date New Zealand and overseas evidence and to make recommendations based on the evidence that will lead to the best practice for patients with NSTEACS in New Zealand.
Date:   Oct 2005

Title:   Angina - myDr.com.au
Publisher:   myDr
Description:   Angina is a crushing pain or feeling of discomfort in the chest, due to inadequate oxygen supply to the heart caused by narrowing of the coronary arteries.
Date:   Aug 2005

Title:   Lipid management
Publisher:   National Heart Foundation of Australia
Description:   The Heart Foundation produces a comprehensive range of independent, evidence-based cardiovascular health information. Documents include Position Statement on Lipid Management (2005).
Date:   Jan 2005

Title:   Guidelines for pre-hospital administration of fibrinolytic therapy by New Zealand general practitioners
Publisher:   Cardiac Society of Australia and New Zealand
Description:   These guidelines have been developed in consultation with the Ministry of Health (NZ) to ensure equity of access to fibrinolytic therapy (previously known as thrombolytic therapy) throughout New Zealand.
Date:   Jan 2004

Title:   Heart attack - myDr.com.au
Publisher:   myDr
Description:   A heart attack (myocardial infarction) occurs when the arterial blood supply to the heart muscle is blocked.
Date:   Mar 2003

Title:   A guideline for the management of heart failure: health professionals guide
Publisher:   National Heart Foundation (NZ)
Description:   This guideline makes recommendations relating to the management of patients with an established diagnosis of congestive heart failure due to systolic ventricular dysfunction. Management of diastolic dysfunction is not included.
Date:   Dec 2001
Results 1 to 20 displayed.
1    2